Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Paul A. Cossum"'
Autor:
Jose R. Rodriguez, John H. Rex, Luis Ostrosky-Zeichner, Paul A. Cossum, Enuo Chen, Victor L. Paetznick, T. O. M. Wallace, Scott A. Bazemore
Publikováno v:
Antimicrobial Agents and Chemotherapy. 45:2781-2786
When nystatin is placed in RPMI and other biological fluids, there is loss of pure nystatin, with the development of two distinguishable chromatographic peaks, 1 and 2. Peak 1 appears identical to commercially prepared nystatin. By nuclear magnetic r
Autor:
C. A. Stein, Joshua Ojwang, Irina V. Lebedeva, Robert R. Rando, Anthony J. Raffo, Paul A. Cossum
Publikováno v:
Journal of Urology. 166:461-469
Purpose: We investigated antisense inhibition of anti-apoptotic bcl-xL and bcl-2 proteins to increase chemosensitization in the T24 and 5637 bladder carcinoma cell lines.Materials and Methods: A T24 bladder carcinoma cell line stably over expressing
Autor:
Melissa C. Marr, Thomas L. Wallace, Paul A. Cossum, Rochelle W. Tyl, Christina B. Myers, Jeffrey L. Larson
Publikováno v:
Toxicological Sciences. 53:421-429
Nyotran is a liposomally encapsulated i.v. formulation of the antifungal polyene nystatin. This drug was evaluated in a series of reproductive toxicity studies, according to the guidelines outlined by the International Conference on Harmonization (IC
Publikováno v:
International Journal of Toxicology. 19:33-42
ATRAGEN® is a liposome-encapsulated intravenous (IV) formulation of the anticancer drug all- trans-retinoic acid (tretinoin). Retinoids as a class of compounds produce a characteristic profile of toxicities collectively known as hypervitaminosis A.
Publikováno v:
Antimicrobial Agents and Chemotherapy. 43:1424-1428
The objective of this study was an interspecies comparison of free nystatin (NYS) and liposomal NYS (Nyotran) distribution in plasma. NYS and liposomal NYS at concentrations of 5, 10, and 20 μg of NYS/ml were incubated in human, dog, and rat plasma
Autor:
Barbara Moffat, Michael Roth, Paul A. Cossum, Sharon A. Chen, Bobbe L. Ferraiolo, Kevin A. Dwyer, Richard Vandlen
Publikováno v:
Pharmaceutical Research. :419-424
The pharmacokinetics and tissue distribution of a human relaxin were investigated after intravenous (iv) bolus administration to pregnant or nonpregnant rats. Human gene-2 relaxin (hRlx-2) serum concentrations after iv bolus administration were descr
Autor:
Scot A. Marsters, Jerome E. Groopman, Paul A. Cossum, Steven M. Chamow, Douglas H. Smith, Randal A. Byrn, Catherine Lucas, Timothy J. Gregory, Jennifer S. Johnson, Joyce Mordenti, Florian M. Wurm, Daniel J. Capon
Publikováno v:
Nature. 344:667-670
Molecular fusions of CD4, the receptor for human immunodeficiency virus (HIV), with immunoglobulin (termed CD4 immunoadhesins) possess both the gp120-binding and HIV-blocking properties of recombinant soluble CD4, and certain properties of IgG, notab
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology. 53(1)
AR177 (Zintevir) is a 17-mer oligonucleotide that has been shown to have anti-HIV activity and to be a potent HIV-1 integrase inhibitor in vitro, and is among the first oligonucleotides to enter human clinical trials. Acute and multiple-dose intraven
Autor:
Joshua O. Ojwang, Steven C. Parrott, Kishor M. Wasan, Paul A. Cossum, Manisha Ramaswamy, Wesley Wong, Thomas L. Wallace, Samson Ng
Publikováno v:
Antimicrobial agents and chemotherapy. 42(7)
The objective of the proposed study was to determine the distribution in plasma lipoprotein of free all- trans retinoic acid (ATRA) and liposomal ATRA (Atragen; composed of dimyristoyl phosphatidylcholine and soybean oil) following incubation in huma
Autor:
Elias Anaissie, Thomas L. Wallace, Paul A. Cossum, Gabriel Lopez-Berestein, John H. Rex, Victor L. Paetznick
The purpose of this study was to examine the activity of liposomal nystatin against a disseminated Aspergillus fumigatus infection in neutropenic mice. Mice were made neutropenic with 5-fluorouracil and were administered the antifungal drug intraveno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53a4ab8ae3b6b5475bbf899d586966a1
https://europepmc.org/articles/PMC164099/
https://europepmc.org/articles/PMC164099/